IRONWOOD PHARMACEUTICALS INC
Ticker: 1446847
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q3 FY23 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 106.51-12.7% | 122.06+43.2% | 85.24+107.2% | 41.14-55.1% | 91.59-3.0% | 94.40+26.1% | 74.88-34.2% | 113.74 |
| Total Income | 106.51-12.7% | 122.06+43.2% | 85.24+107.2% | 41.14-55.1% | 91.59-3.0% | 94.40+26.1% | 74.88-34.2% | 113.74 |
| EXPENSES | ||||||||
| Expenditure | 33.93-27.2% | 46.58+16.7% | 39.92-43.2% | 70.25+6.5% | 65.96-5.0% | 69.42+8.7% | 63.86-13.4% | 73.72 |
| Tax | 24.40-12.7% | 27.94+96.5% | 14.22+1181.1% | 1.11-91.9% | 13.72-30.5% | 19.74+116.4% | 9.12-49.3% | 17.98 |
| PROFIT | ||||||||
| PBT | 65.17-4.2% | 68.02+79.9% | 37.82+204.3% | -36.27-308.8% | 17.37-8.0% | 18.88+280.6% | 4.96-84.5% | 31.93 |
| Net Profit | 40.77+1.7% | 40.08+69.8% | 23.60+163.1% | -37.39-1124.4% | 3.65+524.4% | -0.86+79.3% | -4.16-127.2% | 15.32 |
| KEY METRICS | ||||||||
| OPM % | 68.14%+6.30pp | 61.84%+8.67pp | 53.17%+123.92pp | -70.75%-98.74pp | 27.99%+1.53pp | 26.46%+11.74pp | 14.72%-20.47pp | 35.19% |
| NPM % | 38.28%+5.45pp | 32.84%+5.15pp | 27.69%+118.55pp | -90.87%-94.85pp | 3.98%+4.89pp | -0.91%+4.65pp | -5.56%-19.03pp | 13.47% |
| EPS | 0.25+0.0% | 0.25+66.7% | 0.15+165.2% | -0.23-1250.0% | 0.02+300.0% | -0.01+66.7% | -0.03-130.0% | 0.10 |
Corporate Events
Board MeetingIRWD
202616Jun
Board Meeting
Election of eight director nominees, approval of an amendmen…
SEC Filing ↗ Board MeetingIRWD
202615May
Board Meeting
CFO Transition - Gregory Martini resigns as Senior Vice Pres…
SEC Filing ↗